Search here...
Subscribe

Tag: Biohaven Pharmaceuticals

spot_imgspot_img

Acute migraine? NICE recommends Pfizer’s rimegepant as potential option

News PB Staff Writer -
The National Institute for Health and Care Excellence (NICE) has released conclusive draft guidance, suggesting Pfizer's Vydura (rimegepant) as a choice for treating acute...

Pfizer to pay Biohaven $11.6 bln to tap migraine market

News PB Staff Writer -
Pfizer said on Tuesday it will pay $11.6 billion to buy Biohaven Pharmaceuticals, making a big bet on its ability to boost sales of...

Follow us

Engage with Experts: Connect with industry leaders, renowned pharmacists, and forward-thinking researchers through exclusive live Q&A sessions and engaging discussions. Tap into their wisdom, ask burning questions, and gain invaluable insights to fuel your passion for pharmacy

Company

Latest news

Thousands of illicit medicines seized in Manchester

News 0
These include powerful opioid painkillers and antidepressants, as well...

Valproate National Patient Safety Alert – GPhC tells what pharmacists need to do

News 0
Pharmacy teams should be prepared to discuss the current...

Cases of norovirus in England almost tripled last week

News 0
The number of norovirus, flu and RSV infections are...

Popular news

EXCLUSIVE – Andrew Lane: Empowering pharmacy contactors

BIG INTERVIEW 0
After two days of intense deliberation on the future...

Pharmacy Business Diversity Conference – session summary: ‘Building environment of trust and comfort is must to tackle mental health issues at workplace’

Conference 0
Mental health has become a major concern worldwide and...

ITV invests in pain relief brand Flarin

News 0
ITV on Tuesday (Aug 15) said it had agreed...

Copyright © 2023 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc